Semaglutide and Tirzepatide work by slowing gastric emptying, increasing feelings of fullness, and reducing hunger
10.1172/JCI42285 10 HareK
The medication achieves peak plasma concentrations within 60 minutes and maintains therapeutic levels for 4-6 hours
Prohibited by the World Anti-Doping Agency in competition Product Specifications Format: pre-mixed liquid intranasal spray (1:1 BPC-157 to TB-500 ratio per metered amount) Strength: 60 mg total peptide per 30 mL bottle (30 mg BPC-157 + 30 mg TB-500) Purity: 99% (HPLC verified, each component) Container: sealed metered nasal spray bottle Certificate of Analysis: lot-specific COA available, with separate purity and identity verification for both component peptides See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
Biochem Biophys Res Commun (2018) 506(1):14552
In addition, it was reported that intravenous GLP-1 receptor agonist administration improved flow-mediated dilatation in human subjects 9